Shares of Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 26.50 ($0.35) and traded as high as GBX 26.50 ($0.35). Mereo BioPharma Group plc (MPH.L) shares last traded at GBX 26.50 ($0.35), with a volume of 49,264 shares trading hands.
Mereo BioPharma Group plc (MPH.L) Trading Down 1.9 %
The stock has a 50-day moving average price of GBX 26.50 and a two-hundred day moving average price of GBX 26.50. The stock has a market capitalization of £89.76 million and a PE ratio of -0.21. The company has a debt-to-equity ratio of 164.26, a quick ratio of 2.92 and a current ratio of 2.98.
Mereo BioPharma Group plc (MPH.L) Company Profile
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
Featured Stories
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- What is the Nikkei 225 index?
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- What Makes a Stock a Good Dividend Stock?
- AMD Gains Momentum With AI: Can It Beat Expectations?
- The How and Why of Investing in Gold Stocks
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
